| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Current epidemiology of HCV in Sicily: the RESIST-HCV model
|
Di Marco, V.
|
|
2019
|
51 |
S3 |
p. e262
|
article
|
| 2 |
Editorial Board
|
|
|
2019
|
51 |
S3 |
p. i-ii
|
article
|
| 3 |
Effect of alpha-fetoprotein on survival in HIV-infected patients with hepatocellular carcinoma
|
Messina, E.
|
|
2019
|
51 |
S3 |
p. e260-e261
|
article
|
| 4 |
How does Trieste treat HCV in PWID? An effective coordination between addiction treatment service (SerD), the infective disease department and the liver clinic
|
Masutti, F.
|
|
2019
|
51 |
S3 |
p. e261
|
article
|
| 5 |
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS
|
Miele, L.
|
|
2019
|
51 |
S3 |
p. e263-e264
|
article
|
| 6 |
New reports of curcumine-induced hepatitis
|
Gasbarrini, G.
|
|
2019
|
51 |
S3 |
p. e259
|
article
|
| 7 |
Resources optimization in DAA-based HCV treatment through a simplified on-treatment schedule
|
Pasulo, L.
|
|
2019
|
51 |
S3 |
p. e261-e262
|
article
|
| 8 |
Screening and linkage to care of prisoners with HCV infection: the RESIST-HCV project
|
Prestileo, T.
|
|
2019
|
51 |
S3 |
p. e263
|
article
|
| 9 |
Second-generation DAAs for HCV: real-life efficacy in the RESIST-HCV cohort
|
Cacciola, I.
|
|
2019
|
51 |
S3 |
p. e262-e263
|
article
|
| 10 |
Social and labor market reintegration of the transplanted patient
|
Bellis, L.
|
|
2019
|
51 |
S3 |
p. e259-e260
|
article
|
| 11 |
The ITA.LI.CA network: description and results of its activity
|
Avanzato, F.
|
|
2019
|
51 |
S3 |
p. e260
|
article
|
Journal description